Subscribe
shutterstock_1086968018_jarretera
jarretera / Shutterstock.com
5 April 2019Americas

FDA boosts customs collaboration to fight fake drugs

The  US Food and Drug Administration (FDA) and  US Customs and Border Protection (CBP) have strengthened their collaboration in a bid to halt the import of counterfeit drugs and protect public health.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
FDA warns stem cell company over unapproved treatments
4 June 2019   The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.
Americas
Arizona man sentenced to prison for trafficking counterfeit drugs
8 February 2017   An Arizona-based man was sentenced to more than three years in federal prison for trafficking counterfeit pet pharmaceutical products into the US.


Editor's picks

A step too far? Why Stewart’s approach is dividing opinion
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

Editor's picks

Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025

More on this story

Big Pharma
FDA warns stem cell company over unapproved treatments
4 June 2019   The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.
Americas
Arizona man sentenced to prison for trafficking counterfeit drugs
8 February 2017   An Arizona-based man was sentenced to more than three years in federal prison for trafficking counterfeit pet pharmaceutical products into the US.

More on this story

Big Pharma
FDA warns stem cell company over unapproved treatments
4 June 2019   The US Food and Drug Administration has sent a warning letter to a stem cell company for marketing a number of unapproved treatments for a variety of life-threatening conditions.
Americas
Arizona man sentenced to prison for trafficking counterfeit drugs
8 February 2017   An Arizona-based man was sentenced to more than three years in federal prison for trafficking counterfeit pet pharmaceutical products into the US.

More features

Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?
Broad Institute wins appeal to restore CRISPR patent in Europe
BMS faces fresh lawsuit over alleged cancer drug monopoly
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations
Boies Schiller Flexner adds three-strong litigation team